ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (1): 152-156.doi: 10.6040/j.issn.1673-3770.0.2021.570
SUN Hao1,2, YANG Hui3, LI Jiao4
CLC Number:
| [1] 蒋梦婷, 王海青. 葡萄膜黑色素瘤的放疗方法及其并发症的临床研究进展[J]. 西南国防医药, 2020, 30(1): 79-81. doi:10.3969/j.issn.1004-0188.2020.01.032 JIANG Mengting, WANG Haiqing. Clinical research progress of radiotherapy methods and complications of uveal melanoma[J]. Medical Journal of National Defending Forces in Southwest China, 2020, 30(1): 79-81. doi:10.3969/j.issn.1004-0188.2020.01.032 [2] Koopmans AE, Verdijk RM, Brouwer RW, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma[J]. Mod Pathol, 2014, 27(10): 1321-1330. doi:10.1038/modpathol.2014.43 [3] Gass JD. Problems in the differential diagnosis of choroidal nevi and malignant melanoma. XXXIII Edward Jackson Memorial lecture[J]. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol, 1977, 83(1): 19-48. doi: 10.1089/ten.2005.11.1254 [4] 王依凝, 魏文斌. 葡萄膜黑色素瘤的预后评估[J]. 中国医学前沿杂志(电子版), 2020, 12(12): 11-17. doi:10.12037/YXQY.2020.12-03 WANG Yining, WEI Wenbin. Prognostic evaluation of uveal melanoma[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2020, 12(12): 11-17. doi:10.12037/YXQY.2020.12-03 [5] Fry MV, Augsburger JJ, Corrêa ZM. Clinical features, metastasis, and survival in patients younger than 21 years with posterior uveal melanoma[J]. JAMA Ophthalmol, 2019, 137(1): 75-81. doi:10.1001/jamaophthalmol.2018.5132 [6] 魏文斌, 屠颖. 眼内肿瘤细针穿刺活检的利与弊[J]. 眼科, 2012, 21(4): 217-221. WEI Wenbin, TU Ying. Pros and cons of fine needle aspiration biopsy in ocular tumors[J]. Petroleum Exploration and Development, 2012, 21(4): 217-221. [7] Singh AD, Medina CA, Singh N, et al. Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications[J]. Br J Ophthalmol, 2016, 100(4): 456-462. doi:10.1136/bjophthalmol-2015-306921 [8] Finn AP, Materin MA, Mruthyunjaya P. CHOROIDAL TUMOR BIOPSY: a review of the current state and a glance into future techniques[J]. Retina, 2018, 38(1): S79-S87. doi:10.1097/IAE.0000000000001997 [9] 蔡国平. 细针穿刺活检在葡萄膜黑色素瘤诊断和预后评估中的应用[J]. 中华眼视光学与视觉科学杂志, 2020, 22(2): 81-86. doi:10.3760/cma.j.issn.1674-845X.2020.02.001 CAI Guoping. Diagnosis and prognostic evaluation of uveal melanoma via fine needle aspiration biopsy[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2020, 22(2): 81-86. doi:10.3760/cma.j.issn.1674-845X.2020.02.001 [10] Shields CL, Materin MA, Teixeira L, et al. Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy[J]. Ophthalmology, 2007, 114(10): 1919-1924. doi:10.1016/j.ophtha.2007.04.054 [11] McCannel TA, Chang MY, Burgess BL. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma[J]. Ophthalmology, 2012, 119(3): 606-610. doi:10.1016/j.ophtha.2011.08.046 [12] Corrêa ZM, Augsburger JJ. Indications for fine needle aspiration biopsy of posterior segment intraocular tumors[J]. Am J Ophthalmol, 2019, 207: 45-61. doi:10.1016/j.ajo.2019.05.018 [13] Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review[J]. Acta Ophthalmol, 2009, 87(6): 588-601. doi:10.1111/j.1755-3768.2009.01637.x [14] Midena E, Bonaldi L, Parrozzani R, et al. In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy[J]. Eur J Ophthalmol, 2006, 16(3): 422-425. doi:10.1177/112067210601600310 [15] Eide N, Syrdalen P, Walaas L, et al. Fine needle aspiration biopsy in selecting treatment for inconclusive intraocular disease[J]. Acta Ophthalmol Scand, 1999, 77(4): 448-452. doi:10.1034/j.1600-0420.1999.770419.x [16] Shields CL, Ganguly A, Materin MA, et al. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases[J]. Trans Am Ophthalmol Soc, 2007, 105: 43-52. doi: 10.1001/archopht.125.8.1017 [17] Abi-Ayad N, Grange JD, Salle M, et al. Transretinal uveal melanoma biopsy with 25-gauge vitrectomy system[J]. Acta Ophthalmol, 2013, 91(3): 279-281. doi:10.1111/j.1755-3768.2011.02172.x [18] Reddy DM, Mason LB, Mason JO III, et al. Vitrectomy and vitrector port needle biopsy of choroidal melanoma for gene expression profile testing immediately before brachytherapy[J]. Ophthalmology, 2017, 124(9): 1377-1382. doi:10.1016/j.ophtha.2017.03.053 [19] Sellam A, Desjardins L, Barnhill R, et al. Fine needle aspiration biopsy in uveal melanoma: technique, complications, and outcomes[J]. Am J Ophthalmol, 2016, 162: 28-34.e1. doi:10.1016/j.ajo.2015.11.005 [20] Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review[J]. Acta Ophthalmol, 2009, 87(6): 588-601. doi:10.1111/j.1755-3768.2009.01637.x [21] Bagger M, Tebering JF, Kiilgaard JF. The ocular consequences and applicability of minimally invasive 25-gauge transvitreal retinochoroidal biopsy[J]. Ophthalmology, 2013, 120(12): 2565-2572. doi:10.1016/j.ophtha.2013.07.043 [22] Abi-Ayad N, Grange JD, Salle M, et al. Transretinal uveal melanoma biopsy with 25-gauge vitrectomy system[J]. Acta Ophthalmol, 2013, 91(3): 279-281. doi:10.1111/j.1755-3768.2011.02172.x [23] Grewal DS, Cummings TJ, Mruthyunjaya P. Outcomes of 27-gauge vitrectomy-assisted choroidal and subretinal biopsy[J]. Ophthalmic Surg Lasers Imaging Retina, 2017, 48(5): 406-415. doi:10.3928/23258160-20170428-07 [24] Tang PH, Shields RA, Schefler AC, et al. Biopsy of a choroidal melanoma using transvitreal pars Plana vitrectomy[J]. Ophthalmic Surg Lasers Imaging Retina, 2018, 49(8): 645-647. doi:10.3928/23258160-20180803-16. [25] Finn AP, Materin MA, Mruthyunjaya P. CHOROIDAL TUMOR BIOPSY: a review of the current state and a glance into future techniques[J]. Retina, 2018, 38(1): 79-87. doi:10.1097/IAE.0000000000001997 [26] Hussain RN, Kalirai H, Groenewald C, et al. Prognostic biopsy of choroidal melanoma after proton beam radiation therapy[J]. Ophthalmology, 2016, 123(10): 2264-2265. doi:10.1016/j.ophtha.2016.05.028 [27] Augsburger JJ, Corrêa ZM, Schneider S, et al. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category[J]. Trans Am Ophthalmol Soc, 2002, 100: 225-232. [28] Bagger M, Smidt-Nielsen I, Andersen MK, et al. Long-term metastatic risk after biopsy of posterior uveal melanoma[J]. Ophthalmology, 2018, 125(12): 1969-1976. doi:10.1016/j.ophtha.2018.03.047 [29] 张瑞恒, 李洋, 魏文斌. 葡萄膜黑色素瘤分子预后指标的研究进展[J]. 中国医学前沿杂志(电子版), 2020, 12(12): 4-10. doi:10.12037/YXQY.2020.12-02 ZHANG Ruiheng, LI Yang, WEI Wenbin. Molecular prognosis factors of uveal melanoma: history and current progress[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2020, 12(12): 4-10. doi:10.12037/YXQY.2020.12-02 [30] McCannel TA. Fine-needle aspiration biopsy in the management of choroidal melanoma[J]. Curr Opin Ophthalmol, 2013, 24(3): 262-266. doi:10.1097/ICU.0b013e32835ff001 [31] Correa ZM, Augsburger JJ. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications[J]. Graefes Arch Clin Exp Ophthalmol, 2014, 252(1): 131-135. doi:10.1007/s00417-013-2515-0 [32] 向中正, 刘磊. 葡萄膜黑色素瘤诊疗进展[J]. 华西医学, 2018, 33(11): 1433-1440. doi: 10.7507/1002-0179.201810077 XIANG Zhongzheng, LIU Lei. Progress in diagnosis and treatment of uveal melanoma[J]. West China Medical Journal, 2018, 33(11): 1433-1440. doi: 10.7507/1002-0179.201810077 [33] Field MG, Decatur CL, Kurtenbach S, et al. PRAME as an independent biomarker for metastasis in uveal melanoma[J]. Clin Cancer Res, 2016, 22(5): 1234-1242. doi:10.1158/1078-0432.CCR-15-2071 [34] Field MG, Durante MA, Decatur CL, et al. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas[J]. Oncotarget, 2016, 7(37): 59209-59219. doi:10.18632/oncotarget.10962 [35] Yang J, Manson DK, Marr BP, et al. Treatment of uveal melanoma: where are we now? [J]. Ther Adv Med Oncol, 2018, 10: 1758834018757175. doi:10.1177/1758834018757175 |
| [1] | RAN Li-li1,2， YUAN Gong-qiang2， DONG Xiao-guang2.. Causes and efficacy of vitrectomy for secondary epiretinal membrane [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(3): 47-49. |
|
||